$placeNoAds is not true
placeAds(The mark consists of the wording ALBUMEDIX in black below a design of a stylized red hexagon with curved edges. The hexagon design has a portion of its center and its bottom left edge removed and in white.;In the Statement Class 5 has been updated in accordance with the F-note dated 11/20/2020.;Pharmaceutical compositions and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic reagents for medical use and pharmaceutical medicinal use; protein supplements for pharmaceutical and medical purposes; albuminous preparations for pharmaceutical and medical purposes; recombinant human albumin for pharmaceutical and medical purposes; diagnostic agents for medical imaging * ; pharmaceutical products and preparations for supporting drugs by reducing the time it takes for the body to break down the active pharmaceutical ingredient *;In the statement, Class 5, has been updated in accordance with the F-note dated 2/3/2021.;The color(s) red, black and white is/are claimed as a feature of the mark.;Chemicals for the manufacture of pharmaceutical products; chemical additives used in the manufacture of pharmaceutical preparations; albumin used in industry for the preparation of pharmaceutical compositions, reagents, and diagnostic reagents;Research and development services relating to pharmaceutical products; consultation in the field of development of medicines and pharmaceuticals as well as analysis and development services in the nature of pharmaceutical research and development services;, 'body') is not true
ALBUMEDIX Brand - FindOwnerSearch

ALBUMEDIX

Welcome to the Brand page for “ALBUMEDIX”, which is offered here for The mark consists of the wording albumedix in black below a design of a stylized red hexagon with curved edges. the hexagon design has a portion of its center and its bottom left edge removed and in white.;in the statement class 5 has been updated in accordance with the f-note dated 11/20/2020.;pharmaceutical compositions and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic reagents for medical use and pharmaceutical medicinal use; protein supplements for pharmaceutical and medical purposes; albuminous preparations for pharmaceutical and medical purposes; recombinant human albumin for pharmaceutical and medical purposes; diagnostic agents for medical imaging * ; pharmaceutical products and preparations for supporting drugs by reducing the time it takes for the body to break down the active pharmaceutical ingredient *;in the statement, class 5, has been updated in accordance with the f-note dated 2/3/2021.;the color(s) red, black and white is/are claimed as a feature of the mark.;chemicals for the manufacture of pharmaceutical products; chemical additives used in the manufacture of pharmaceutical preparations; albumin used in industry for the preparation of pharmaceutical compositions, reagents, and diagnostic reagents;research and development services relating to pharmaceutical products; consultation in the field of development of medicines and pharmaceuticals as well as analysis and development services in the nature of pharmaceutical research and development services;.

Its status is currently believed to be active. Its class is unavailable. “ALBUMEDIX” is believed to be currently owned by “ALBUMEDIX LTD”.


Owner:
ALBUMEDIX LTD
Owner Details
Description:
The mark consists of the wording ALBUMEDIX in black below a design of a stylized red hexagon with curved edges. The hexagon design has a portion of its center and its bottom left edge removed and in white.;In the Statement Class 5 has been updated in accordance with the F-note dated 11/20/2020.;Pharmaceutical compositions and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic reagents for medical use and pharmaceutical medicinal use; protein supplements for pharmaceutical and medical purposes; albuminous preparations for pharmaceutical and medical purposes; recombinant human albumin for pharmaceutical and medical purposes; diagnostic agents for medical imaging * ; pharmaceutical products and preparations for supporting drugs by reducing the time it takes for the body to break down the active pharmaceutical ingredient *;In the statement, Class 5, has been updated in accordance with the F-note dated 2/3/2021.;The color(s) red, black and white is/are claimed as a feature of the mark.;Chemicals for the manufacture of pharmaceutical products; chemical additives used in the manufacture of pharmaceutical preparations; albumin used in industry for the preparation of pharmaceutical compositions, reagents, and diagnostic reagents;Research and development services relating to pharmaceutical products; consultation in the field of development of medicines and pharmaceuticals as well as analysis and development services in the nature of pharmaceutical research and development services;
Categories: